On September 1st, Lepu Medical’s AI-ECG Tracker received China NMPA Registration Certificate for class III medical devices. Previously, AI-ECG Tracker has already obtained CE marking in 2019 and FDA approval in 2020.
At the same time, AI-ECG Tracker has become the fourth AI product of Lepu that has received China NMPA Registration Certificate for class III medical devices after the AI-ECG Platform, the OmniECG B120 and the OmniECG C120.
The functional modules of Lepu’s AI-ECG Tracker consist of system management client terminal, doctor diagnosis client terminal and ECG analysis client terminal. With greater speed, accuracy and comprehensiveness, AI-ECG Tracker can be used in conjunction with Lepu’s smart terminal devices to assist in analyzing ECG data and greatly reduce the workload of ECG interpretation.